Enova Q2 Earnings Beat Sends Stock Up 8.9%

NEW YORK, July 26 —

Enova International's Q2 2026 earnings per share came in at $3.87 against an analyst consensus of $3.68, sending shares up 8.9% in a single session. Three consecutive quarters of estimates beaten, 31.1% revenue growth, and an 83.3% gross margin tell one story. The $21.72 million in insider stock sales over the past 90 days, with zero open-market purchases recorded, quietly tells another.

Three for Three

Consumer lenders rarely get to build a reputation for beating Street estimates. Enova has now done it three consecutive quarters: $3.36 vs. $3.03 in Q4 2025, $3.46 vs. $3.17 in Q1 2026, and $3.87 vs. $3.68 in Q2.

At 11.5x forward earnings and a $5.91 billion market cap, the stock trades at a discount that looks either genuinely cheap or appropriately skeptical depending on which signal carries more weight. TD Cowen forecasts stronger price appreciation; the consensus analyst price target of $254.57 implies roughly 7% upside from the $237.27 share price.

The Selling Pattern

What the earnings headline obscures: Executive Chairman David Fisher has been a systematic seller throughout the rally. On June 17, Fisher exercised options at $20.73 per share and sold 33,060 shares at $199.05, collecting $6.58 million. On July 14 and July 15, after the stock had climbed further, he repeated the move. Options again exercised at $20.73, followed by 17,006 shares sold at $231.51 ($3.94 million) and 11,494 shares at $231.45 ($2.66 million).

The $20.73 option exercise price is the tell. These are legacy compensation grants converted to cash at current market prices, not a deliberate reduction in a stake built at market rates. The economic incentive to keep selling at any price north of $20.73 is essentially frictionless.

Fisher isn't the only insider at the window. Per Form 4 filings, Mark Tebbe sold 20,000 shares for approximately $4.03 million on June 18. William M. Goodyear logged three separate sales between May and June. Linda Johnson Rice sold 1,300 shares in late May. In aggregate, insiders including Fisher, Tebbe, Goodyear, and Rice sold approximately $21.72 million over 90 days, with no recorded open-market purchase among them.

Reading the Signal

Insider selling after a stock has appreciated more than tenfold from the option strike price is not inherently alarming; compensation plans exist to be monetized. But the breadth of selling across multiple executives and directors, combined with the complete absence of any open-market buying, is a data point that investors who watch Form 4 filings tend not to ignore.

The business itself is running well. Revenue grew 31.1% year over year to $1.69 billion trailing twelve months. An 83.3% gross margin is exceptional for a financial services company. An 11.5x forward P/E on a 31%-growth business either reflects a genuine value opportunity or embeds a risk the market has priced but not yet publicly articulated.

What to Watch

The next quarterly report is the cleanest checkpoint. Three consecutive beats have recalibrated expectations upward; a fourth would narrow the case for caution, while a miss would make the insider selling pattern feel prescient in retrospect.

Credit quality is the variable that matters most at an online consumer lender. Enova's margins suggest pricing power, but no cycle has fully stress-tested the portfolio. Any deterioration in charge-off rates or net revenue per loan would reprice the stock faster than the multiple math suggests. The constructive case, grounded in three EPS beats and TD Cowen's $254.57 target, is real. So is the $21.72 million in net selling with nothing coming the other direction.

For a fuller picture of the credit metrics and portfolio trends driving Enova's margin profile, run the free Enova International, Inc. deep-dive → /stock/enva.

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

What were Enova's Q2 2026 earnings results?

Enova International reported Q2 2026 EPS of $3.87, beating the analyst consensus of approximately $3.68. The results were disclosed in an 8-K filed with the SEC on July 23, 2026, and shares gained 8.9% in the session following the release.

Has Enova beaten earnings estimates consistently?

Yes. Enova has beaten analyst EPS estimates in each of the three most recent quarters: Q4 2025 ($3.36 vs. $3.03 estimate), Q1 2026 ($3.46 vs. $3.17), and Q2 2026 ($3.87 vs. $3.68). The streak spans roughly nine months of consistent outperformance against Wall Street expectations.

Why are Enova insiders selling stock?

Executive Chairman David Fisher has sold shares following option exercises at a $20.73 strike price, well below current market levels, which is a standard compensation monetization pattern. The broader picture includes multiple insiders — Mark Tebbe, William M. Goodyear, and Linda Johnson Rice among them — selling a combined $21.72 million over 90 days with zero open-market purchases recorded across the group.

What is Enova International's stock price target?

The consensus analyst price target for ENVA is $254.57, versus a recent share price of $237.27, implying approximately 7% upside. TD Cowen specifically forecasts strong price appreciation for the stock.

What is Enova's valuation and growth profile?

Enova trades at 11.5x forward earnings with a market capitalization of approximately $5.91 billion. The company reported trailing-twelve-month revenue of $1.69 billion, representing 31.1% year-over-year growth, with a gross margin of 83.3%.